HLB Pharmaceutical Co., Ltd. (KOSDAQ: 047920)
South Korea
· Delayed Price · Currency is KRW 23,200
-200 (-0.85%)
Dec 19, 2024, 3:00 PM KST
64.19% (1Y)
| Market Cap | 320.16B |
| Revenue (ttm) | 36.10B |
| Net Income (ttm) | 472.66M |
| Shares Out | 14.04M |
| EPS (ttm) | 34.13 |
| PE Ratio | 677.37 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 281,073 |
| Open | 22,800 |
| Previous Close | 23,400 |
| Day's Range | 22,600 - 24,000 |
| 52-Week Range | 12,880 - 42,050 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |